Calton & Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Sell |
5,433
-229
| -4% | -$19K | 0.08% | 216 |
|
|
2025
Q1 | $459K | Buy |
5,662
+175
| +3% | +$14.2K | 0.1% | 181 |
|
|
2024
Q4 | $494K | Buy |
+5,487
| New | +$494K | 0.22% | 105 |
|
|
2024
Q3 | – | Sell |
-5,527
| Closed | -$512K | – | 281 |
|
|
2024
Q2 | $512K | Sell |
5,527
-598
| -10% | -$55.4K | 0.26% | 89 |
|
|
2024
Q1 | $581K | Buy |
6,125
+34
| +0.6% | +$3.23K | 0.28% | 84 |
|
|
2023
Q4 | $544K | Buy |
+6,091
| New | +$544K | 0.22% | 102 |
|
|
2023
Q3 | – | Sell |
-6,085
| Closed | -$506K | – | 260 |
|
|
2023
Q2 | $506K | Buy |
6,085
+135
| +2% | +$11.2K | 0.24% | 105 |
|
|
2023
Q1 | $453K | Buy |
5,950
+40
| +0.7% | +$3.05K | 0.21% | 108 |
|
|
2022
Q4 | $491K | Buy |
5,910
+3,045
| +106% | +$253K | 0.19% | 129 |
|
|
2022
Q3 | $227K | Sell |
2,865
-2
| -0.1% | -$158 | 0.13% | 180 |
|
|
2022
Q2 | $212K | Buy |
+2,867
| New | +$212K | 0.12% | 205 |
|
|
2018
Q3 | – | Sell |
-2,117
| Closed | -$202K | – | 315 |
|
|
2018
Q2 | $202K | Buy |
+2,117
| New | +$202K | 0.06% | 267 |
|
|
2018
Q1 | – | Sell |
-1,651
| Closed | -$158K | – | 1288 |
|
|
2017
Q4 | $158K | Buy |
+1,651
| New | +$158K | 0.04% | 390 |
|